ELOXX PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ELOXX PHARMACEUTICALS, INC. (ELOX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $740.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2023-03-31
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $740.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $715.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $404.00K.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $556.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2022-12-31 | $740.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $715.00K 10-K · filed 2022-03-30 |
| 2020-12-31 | $404.00K 10-K · filed 2021-03-12 |
| 2019-12-31 | $556.00K 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |